Skip to content

Belgomed

Active
Private limited companyfounded 20242 yrs activeTrichterheideweg 11, 3500 Hasselt, BelgiumKBO/BCE: BE 1012.733.943

The computed 12-month bankruptcy probability of Belgomed is 1.6% (moderate). The 2025 annual accounts show equity of €74k and a net result of €44k. Its solvency ranks better than 48% of 11210 sector peers (fiscal year 2025). The company has been active since 2024 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Score 2025
70 / 100
Healthy
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes
Profitability97
Solvency65
Growth-
Track record67
Bankruptcy probability, 12 months
1.6% Moderate
0%0.5%1.5%4%10%≥ 25%
Credit up to €5k at 30 days acceptable
Liquidity ample (current ratio 1.66; short-term debt: 59.8% and cash: 36.9% of total assets), but 59.8% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Five signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Young company
A young company has little track record yet and statistically fails more often than an established one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 2 years 0 10 y
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
40.2%
Return on assets
23.9%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 08-07-2026, 23 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
23 d early
← before the deadline after the deadline →
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, micro schema

Equity
€74k
Total assets
€184k
Net result
€44k
Working capital
€73k

Turnover and EBIT margin not published: the micro schema does not require them.

Balance-sheet composition
Assets €184k
Fixed assets €1k
Current assets €183k
Equity and liabilities €184k
Equity €74k
Debt €110k
Debt finances 59.8% of the balance-sheet total.
Key figures and ratios
2025 value
Solvency
40.2%
Current ratio
1.66
Quick ratio
1.63
Debt / equity
1.49
ROE
59.5%
ROA
23.9%
Debt
€110k
Debt ≤ 1 year
€110k
Income taxes
€15k
Filed annual accounts
As filed with the NBB · 2025
Balance sheet Code2025
Assets
Total assets20/58€184k
Fixed assets21/28€1k
Financial fixed assets28€1k
Current assets29/58€183k
Stocks and contracts in progress3€4k
Stocks30/36€4k
Amounts receivable within one year40/41€112k
Trade receivables40€83k
Other amounts receivable41€28k
Cash at bank and in hand54/58€68k
Equity and liabilities
Total equity and liabilities10/49€184k
Equity10/15€74k
Contributions10/11€30k
Profit (loss) carried forward14€44k
Amounts payable17/49€110k
Amounts payable within one year42/48€110k
Trade debts44€95k
Suppliers440/4€95k
Taxes, remuneration and social security45€15k
Taxes450/3€15k
Other amounts payable47/48€266
Income statement Code2025
Other operating charges640/8€227
Gross operating margin9900€60k
Operating profit (loss)9901€59k
Financial charges65/66B€116
Recurring financial charges65€116
Profit (loss) for the period before taxes9903€59k
Income taxes67/77€15k
Profit (loss) for the period9904€44k
Profit (loss) for the period to be appropriated9905€44k
Appropriation of the result
Profit (loss) to be appropriated9906€44k

The notes to these accounts (3 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

2026
08-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
NBB filing

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Hasselt · 1 establishment unit since 2024
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Trichterheideweg 113500 Hasselt
Ground area
3.7 ha
Building footprint
1,636 m²
Parcel 71323C0727/00C000, Flanders. Linked by address, not a title deed.
1 establishment unit
Belgomed
Trichterheideweg 11, 3500 HasseltManufacture of medical and dental instruments and supplies
since 20242.365.200.488
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
71323C0727/00C000 Flanders 3.7 ha 1 · 1,636 m² -
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Of 1,896 companies in sector 46460 we hold annual accounts for 1,116. 552 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded23-08-2024
Fiscal year end31-12
Activities, NACEBEL
46460Wholesale of pharmaceutical and medical goods
Sources
Crossroads Bank for EnterprisesNational Bank · 1 filingAddress and cadastre registers

Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.